-transparent.png){kind=logo}
Two E-rosette (spontaneous rosette with sheep red blood cells)-forming lymphoid cell lines were established. One (HPB-ALL) was derived from a young male Japanese patient with acute lymphoblastic leukemia (ALL), and the other (HPB-MLT) was from a 62-year-old female Japanese patient with a leukemic T-lymphoid malignancy. Formation of E rosettes, absence of any immunoglobulin determinants, absence of EBNA (Epstein-Barr virus associated nuclear antigen) and very limited stimulating ability in mixed lymphocyte culture, were characteristics mostly identical with those of so far established T-cell-derived lymphoid cell lines, MOLT, CCRF-CEM, CCRF-HS-B2, RPMI-8402 and JM. Only HPB-MLT, however, has been derived from an aged patient with T-lymphoid malignancy.
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
May 1972,
Orvosi hetilap,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
January 1978,
Nihon rinsho. Japanese journal of clinical medicine,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
September 1972,
Journal of the National Cancer Institute,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
January 1979,
Scandinavian journal of immunology,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
August 1979,
Clinical immunology and immunopathology,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
March 1977,
Blut,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
January 1979,
The Indian journal of medical research,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
January 1981,
European journal of gynaecological oncology,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
May 1978,
Acta neurologica Scandinavica,
S Morikawa, and
E Tatsumi, and
M Baba, and
T Harada, and
K Yasuhira
May 1974,
Journal of the National Cancer Institute,
